BioMark Diagnostics's market cap is currently C$19.99M. The company's EPS TTM is C$-0.022; its P/E ratio is ―; BioMark Diagnostics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	C$ 163.22K	C$ 153.49K	C$ 43.93K	C$ 0.00	C$ 263.28K
Gross Profit	C$ 163.22K	C$ -232.70K	C$ 43.93K	C$ -13.69K	C$ 263.28K
Operating Income	C$ -1.32M	C$ -1.84M	C$ -1.28M	C$ -1.09M	C$ -1.18M
EBITDA	C$ -919.05K	C$ -1.35M	C$ -1.22M	C$ -1.08M	C$ -1.20M
Net Income	C$ -1.43M	C$ -1.84M	C$ -1.45M	C$ -1.09M	C$ -1.22M
Balance Sheet
Cash & Short-Term Investments	C$ 156.75K	C$ 72.04K	C$ 382.71K	C$ 877.68K	C$ 611.80K
Total Assets	C$ 1.09M	C$ 732.29K	C$ 1.47M	C$ 952.94K	C$ 637.29K
Total Debt	C$ 805.93K	C$ 823.87K	C$ 1.05M	C$ 119.32K	C$ 8.66K
Net Debt	C$ 649.18K	C$ 751.83K	C$ 666.69K	C$ -758.35K	C$ -603.14K
Total Liabilities	C$ 1.70M	C$ 1.88M	C$ 2.11M	C$ 1.03M	C$ 1.08M
Stockholders' Equity	C$ -609.61K	C$ -1.15M	C$ -635.69K	C$ -79.09K	C$ -439.13K
Cash Flow
Free Cash Flow	C$ -986.91K	C$ -919.72K	C$ -1.26M	C$ -455.55K	C$ -454.57K
Operating Cash Flow	C$ -982.52K	C$ -914.42K	C$ -1.20M	C$ -455.55K	C$ -453.79K
Investing Cash Flow	C$ -4.39K	C$ -5.30K	C$ -59.20K	C$ -3.20K	C$ -790.00
Financing Cash Flow	C$ 1.07M	C$ 609.05K	C$ 768.16K	C$ 724.63K	C$ 1.05M

Currency in CAD

BioMark Diagnostics Earnings and Revenue History

Income Statement >

BioMark Diagnostics Debt to Assets

Balance Sheet >

BioMark Diagnostics Cash Flow

Cash Flow >

BioMark Diagnostics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing